๐Ÿ“– Complete Guideโœ… Updated 2026๐Ÿ”ฌ Evidence-Based

Stopping GLP-1

Discontinuation and Regain Prevention Plan

If you are stopping GLP-1, use a structured discontinuation plan with taper strategy, monitoring windows, and regain prevention triggers.

A practical stop plan with objective checkpoints

Stopping GLP-1 without a plan usually turns into rapid appetite rebound and weight regain. A structured discontinuation protocol can reduce slope, improve control, and protect long-term outcomes.

This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.

Discontinuation strategy fundamentals

Execution quality, not novelty, usually determines outcome quality. Keep the protocol simple, measurable, and reviewable every week. When variables change, tag the change and monitor the next 7 to 14 days as a dedicated observation window before making additional adjustments.

Discontinuation checklist

This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.

Decision matrix

Control Why it matters What to track Escalation trigger

This aspect of the Glp1 Discontinuation Regain Prevention protocol is particularly important for users who are tracking their response data systematically. Documenting your experience at each stage provides the longitudinal evidence needed to evaluate protocol effectiveness and make informed adjustments. Shotlee captures these data points automatically, building a comprehensive record that supports evidence-based decision making with your healthcare provider.

Execution playbook

How Shotlee helps

shotleeFeatures

Guide FAQs

If you are stopping GLP-1, use a structured discontinuation plan with taper strategy, monitoring windows, and regain prevention triggers.

Yes. Shotlee supports tracking doses, side effects, and health metrics. It is free.

References

  1. [1]Clinical TrialWilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes Obes Metab. 2022;24:1553-1564.
  2. [2]Clinical TrialGarvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083-2091.
  3. [3]Clinical TrialAronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38-48.

Track Your GLP-1 Discontinuation Regain Prevention Protocol in Shotlee

Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.

๐Ÿš€ Use Shotlee for Free